Invention Grant
- Patent Title: Virus detection
-
Application No.: US14906436Application Date: 2014-07-03
-
Publication No.: US10174069B2Publication Date: 2019-01-08
- Inventor: Rob Field , Martin Rejzek , Abdul Rashid , David Andrew Russell , Maria Jose Marin Altaba
- Applicant: ICENI DIAGNOSTICS LIMITED
- Applicant Address: GB Norwich
- Assignee: ICENI DIAGNOSTICS LIMITED
- Current Assignee: ICENI DIAGNOSTICS LIMITED
- Current Assignee Address: GB Norwich
- Agency: Nixon Peabody LLP
- Agent Mark J. FitzGerald; Teresa A. Ptashka
- Priority: GB1313201.4 20130724
- International Application: PCT/GB2014/052026 WO 20140703
- International Announcement: WO2015/011441 WO 20150129
- Main IPC: C07H23/00
- IPC: C07H23/00 ; C07H15/04 ; G01N33/569 ; G01N33/58

Abstract:
The invention provides methods and materials for use in the detection of influenza viruses which utilise a nanoparticle, for example gold nanoparticle, probe comprising a plurality of glycoconjugate ligands, each glyconjugate ligand (GL) having a plurality of sialic-acid containing recognition group (Y) coupled to the nanoparticle via a multivalent core (X), wherein the multivalent core (X) is a trivalent core, whereby there are 3 recognition groups per ligand, wherein the recognition groups on the bioconjugate specifically bind to the hemagglutinin on the target influenza virus. The probes may include further ligands bound to the nanoparticle which do not bind specifically to an influenza virus—for example polyethylene glycol groups. These can modulate density of the glycoconjugate ligand on the surface of the nanoparticle. Binding of probes is detected by a plasmonic signal which is specific to the influenza virus.
Public/Granted literature
- US20160185814A1 VIRUS DETECTION Public/Granted day:2016-06-30
Information query